Anthropic has issued a pointed warning to investors navigating the increasingly busy world of private-market trading: several secondary platforms that claim to provide access to Anthropic shares are not authorized by the company to facilitate buying or selling.
The message, reported in connection with Anthropic’s communications to market participants, names a specific set of firms—Open Doors Partners, Unicorns Exchange, Pachamama Capital, Lionheart Ventures, Hiive, Forge Global, Sydecar, and Upmarket—stating that these companies are not authorized to provide access to Anthropic shares. For investors, the practical takeaway is straightforward but easy to overlook in the rush to find liquidity: if a platform is offering a path into a private company’s cap table, that does not automatically mean the issuer recognizes or permits that path.
This is not just a legal footnote. In private markets, where information is fragmented and transactions can be opaque, authorization signals something fundamental: whether the issuer (or its transfer agent) will recognize the transaction mechanics, whether the shares being traded are properly transferable under the company’s governing documents, and whether the platform is operating within the boundaries the company intends.
To understand why this matters, it helps to zoom out on how secondary share trading typically works for high-demand private companies. Unlike public stocks—where exchanges, clearinghouses, and regulators create a standardized pipeline—private-company share transfers often depend on a patchwork of contractual rules. These can include rights of first refusal, transfer restrictions in shareholder agreements, board or company consent requirements, lockups, and limitations tied to investor eligibility. Even when a seller and buyer agree on price, the transaction may still fail at the final step if the company refuses to register the transfer or if the shares are not actually eligible to move.
That’s where “access” becomes a loaded word. Some platforms describe themselves as marketplaces, others as brokers, and others as intermediaries that connect buyers and sellers. But the issuer’s authorization determines whether those connections translate into real, registrable ownership changes—or whether they remain informal arrangements that can unravel later.
Anthropic’s warning suggests the latter risk is not hypothetical.
A unique angle here is that the warning doesn’t appear to target a single platform or a single type of activity. Instead, it lists multiple firms across the secondary ecosystem. That breadth implies Anthropic is addressing a pattern: platforms marketing themselves as conduits to Anthropic equity, potentially without the company’s blessing. For investors, this raises a question that goes beyond any one name: how many “secondary” offerings are truly issuer-aligned, and how many are simply aggregating demand around a popular asset?
In the current private-market environment, demand for shares in AI leaders can be intense. When a company is perceived as both strategically important and financially resilient, its equity becomes a proxy for future growth. That demand creates an incentive for platforms to offer “liquidity solutions,” even when the underlying transfer process remains constrained. The result is a marketplace dynamic where the buyer experience can look similar across platforms—forms to fill out, terms to review, timelines to promise—while the issuer’s willingness to validate the transaction can differ dramatically.
Anthropic’s named list functions like a filter. It tells investors: don’t assume that because a platform is active, reputable-sounding, or widely discussed, it is authorized to move Anthropic shares. Authorization is not a branding exercise; it’s a permission structure.
So what should investors do with this information?
First, treat platform claims as starting points, not conclusions. If you’re considering a trade, you should ask direct questions about how the transaction would be executed and recorded. Who initiates the transfer? Would the company or its transfer agent need to approve the transfer? Are there conditions tied to shareholder status, investor accreditation, or residency? What documentation would be provided to confirm that the shares are eligible for transfer and that the buyer will receive registrable ownership?
Second, verify whether the platform is acting as a broker with appropriate authority or as a facilitator that may not control the final transfer outcome. In private markets, the difference between “we connect you” and “we execute a transfer that the issuer will register” can be enormous. Anthropic’s warning indicates that at least some platforms in its list fall into the category of “access” that Anthropic does not authorize.
Third, consider the timeline risk. Secondary trades can take longer than expected because approvals and paperwork are not standardized. If a platform is not authorized, the process may stall at the point where issuer consent or transfer registration is required. That can leave investors exposed to opportunity cost, changing market sentiment, and—depending on the structure—potentially non-refundable deposits or contractual penalties.
Fourth, evaluate counterparty risk. Even if a platform is not authorized by the issuer, it might still facilitate a transaction between parties. But the question becomes: what exactly is being transferred? Is it actual equity, or is it an economic interest, a derivative-like arrangement, or a contract that resembles ownership without conferring the same rights? Investors should be cautious about confusing “economic exposure” with “share ownership,” especially when the issuer is explicitly warning that certain platforms are not authorized to provide access to buy or sell its shares.
There’s also a broader governance implication. Issuers issue warnings like this to protect the integrity of their cap table and to reduce the risk of unauthorized transfers. In a world where private companies can have complex shareholder structures—employee pools, venture investors, strategic holders, and sometimes special classes—uncontrolled trading can complicate administration and dilute clarity. By naming specific platforms, Anthropic is effectively drawing a boundary around who can represent itself as a legitimate channel for Anthropic equity.
This is particularly relevant for investors who may be new to private-market investing. Many people enter the space through the promise of early access and the potential for outsized returns. But private-market investing is not only about selecting the right company; it’s also about selecting the right execution pathway. A great deal can become a bad deal if the transfer mechanics are flawed or if the issuer refuses to recognize the transaction.
At the same time, it’s worth acknowledging that secondary markets exist for a reason. Liquidity is valuable. Employees and early investors often want partial exits. Long-term holders may rebalance portfolios. And new investors may want exposure without waiting for an IPO. The existence of secondary platforms reflects real demand.
But demand does not override authorization. If anything, the more valuable the asset, the more important it is to ensure that the “liquidity” being offered is real liquidity—meaning shares that can be transferred and registered according to the company’s rules.
Anthropic’s warning also highlights a tension that has been growing across private markets: the gap between marketing language and legal reality. Platforms may use terms like “market,” “exchange,” or “access,” which can create an expectation of legitimacy similar to public markets. Yet private-company equity is governed by private contracts and issuer discretion. Without issuer alignment, the platform’s role can be limited to matchmaking or to arranging agreements that still require the company’s approval.
That’s why the warning is significant even if the named platforms are otherwise well-known. A platform can be competent at facilitating conversations and still be unauthorized to provide access to a particular issuer’s shares. Competence in operations is not the same as authorization from the issuer.
For investors, the most useful mindset shift is to treat issuer warnings as part of due diligence rather than as noise. In public markets, regulatory disclosures and exchange rules provide a baseline of trust. In private markets, trust must be earned through verification. When an issuer says certain platforms are not authorized, it’s offering a shortcut to risk reduction—an explicit signal that can save investors from spending time and money on transactions that may not complete.
There’s also a reputational dimension. When issuers publicly name platforms, it can influence how other investors perceive those platforms’ practices. Even if a platform believes it is operating within a gray area, the issuer’s statement can change the risk calculus for counterparties. Buyers may hesitate. Sellers may reconsider. Legal teams may demand additional documentation. Over time, this can reshape the competitive landscape of secondary trading.
But perhaps the most interesting part of this story is what it reveals about the future of private-market infrastructure. As AI companies continue to attract massive attention, the secondary market will likely keep expanding. More platforms will emerge, and more investors will seek ways to participate before public listings. Yet issuer authorization will remain a gatekeeper function. The winners in this environment may not be the platforms with the most aggressive marketing, but those that can demonstrate compliance, transparency, and issuer-aligned processes.
In other words, the “market” is not just where buyers and sellers meet. It’s also where issuers decide which channels are legitimate.
If you’re an investor evaluating a secondary opportunity involving Anthropic shares, the immediate action is to cross-check the platform against Anthropic’s warning. If the platform is among those named as not authorized, you should assume the transaction may not be recognized or completed in the way the platform implies. That doesn’t necessarily mean every interaction is fraudulent, but it does mean the issuer has drawn a line—and crossing it can carry real consequences.
Beyond that, investors should build a checklist that goes deeper than platform reputation. Ask for clarity on transfer eligibility, consent requirements, and the exact form of ownership being acquired. Request documentation that ties the transaction to registrable shares. Confirm whether the company or its transfer agent will process the transfer. Understand the timeline and what happens if approvals are delayed or denied. And if the platform cannot provide clear answers, treat that as a red flag.
Finally, consider the opportunity cost of uncertainty. Private-market deals can be tempting because they promise access to assets before they become widely available. But uncertainty about authorization can turn a potentially profitable trade into a stalled process. In fast-moving sectors like AI, sentiment can shift quickly. A deal that takes months to resolve can lose its economic rationale even if the eventual transfer is approved.
Anthropic’s warning is therefore best read as a reminder that private-market investing is not only about valuation—it’s about process. The process